Tuberous breasts are a congenital difference in breast development that becomes visible at puberty. A tight fibrous ring at the base of the breast prevents the gland from spreading normally across the chest wall, which gives the breast a narrow footprint, an elongated shape and often a wide areola with breast tissue herniating into it. Correction is surgical, it combines three distinct manoeuvres, and it frequently takes more than one operation. This article explains the signs that identify the condition, the three-grade classification surgeons work from, the techniques available, and what published studies actually report about outcomes, revision rates and breastfeeding.
Breast size and shape vary enormously between women, and that variation is not a medical condition. Tuberous breasts are something different: a developmental deficiency of the mammary gland, mainly in its lower and medial portions, combined with a constricting ring at the base of the breast. That is what separates them from breast ptosis, where the gland developed normally and later descended with age, pregnancy or weight change. The burden women describe is primarily psychological, and it is usually sharper when the two breasts are markedly asymmetrical.
One point about frequency needs correcting, because figures circulate online that no study supports. The authors of the reference review published in the Annales de Chirurgie Plastique Esthétique state plainly that the incidence is unknown, precisely because milder forms are harder to diagnose and go unrecorded. Cleveland Clinic says the same thing: the exact rate of occurrence is not established and many cases are never diagnosed. What is documented is that the condition appears only during breast development at puberty, that it affects the shape of the breast rather than the health of the woman, and that it is distress, not physical risk, that brings patients to a consultation.
The origin is congenital without being hereditary. The accepted hypothesis is an abnormality in the way the mammary gland attaches to the pectoral muscle and to the skin, which restricts the breast from expanding at the moment it should be growing. The consequence is read in the shape of the breast rather than in its volume.
The features that identify a tuberous breast are:
The most consistent sign is the constricting ring itself. It explains the shape, and it is the first thing surgery has to address.
Surgeons work from the classification published by Grolleau in 1999, which describes three types according to which quadrants of the breast are deficient. It guides the choice of technique; it is not a measure of medical seriousness.
| Grolleau grade | What the breast lacks |
|---|---|
| Grade I | Lower inner quadrant is absent |
| Grade II | Both lower quadrants are absent |
| Grade III | Very narrow base, tubular shape |
In grade I the areola points downwards and inwards, and correction is the most straightforward of the three. In grade II the breast takes on a funnel shape, the areola points downwards and asymmetry between the sides is common. In grade III the base is severely constricted in both dimensions, the domed areola sits on no underlying volume, and surgery becomes a reconstruction. In a Spanish series of 50 patients operated on between 2020 and 2025, the distribution was 62% grade I, 30% grade II and 8% grade III, which gives a sense of proportion without describing the general population.
The diagnosis is clinical. It rests on an examination of the shape and base of the breast by a GP, a gynaecologist or a breast surgeon, and no imaging is needed to make the diagnosis itself. Any unusual change in shape or growth noticed during adolescence should be raised with a doctor.
The usual rule is to wait until puberty has finished, or at least three years after periods begin, before considering correction. The reasons are concrete: the breast is still changing during adolescence, weight is often unstable, the risk of hypertrophic or keloid scarring is higher, an episode of acne raises the risk of infection, and disturbances of areolar sensitivity can occur at an age when they weigh on quality of sexual life. An implant placed too early also commits the patient to repeated changes.
The rule allows exceptions. The authors of the French review devoted to breast surgery before the end of puberty argue that correction can reasonably be discussed around puberty in selected cases, given the clear psychological impact of the deformity, while stressing that the decision is made case by case and requires the agreement of both parents.
The operation has three objectives: widen the base of the breast by releasing the constricting ring, redistribute or add volume in the lower pole, and correct the areola where it is too wide or too domed. Which techniques are combined depends on the grade, the quality of the skin and the volume available, and it is discussed with the patient, not fixed in advance.
Two consultations with the surgeon usually precede surgery. They serve to examine the breasts, establish what the patient is hoping for, set out the limits of what can be achieved, and agree the strategy, including when that strategy involves more than one operation. A full medical examination, sometimes a mammogram or a breast ultrasound scan, and an appointment with the anaesthetist complete the pathway. Pre-operative instructions cover stopping smoking and alcohol and pausing certain medicines and supplements in the days beforehand.
Correction is carried out under general anaesthetic. It lasts between forty minutes and two hours depending on which manoeuvres are combined, and the hospital stay is short: in a Finnish series of 129 patients, the mean stay was 1.7 days after lipofilling and 2.1 days after implant placement.
Three stages structure the procedure:
These steps are most often carried out through a single incision around the areola.
For grade I, first-line treatment combines fasciotomies, which release the fibrous ring, with lipofilling to relax the breast and restore its curve. Areolar reduction is frequently added.
For grade II, a breast lift, or mastopexy, corrects the shape by removing excess skin, with volume restored by lipofilling or by an implant, and areolar plasty where the size or asymmetry of the areolae calls for it.
For grade III, correction becomes complex and is often planned as two operations three to six months apart. It combines lowering of the inframammary fold, a ptosis correction and breast plasty, with lipofilling or implants to restore volume. The periareolar incision may then be extended by a vertical incision running from the areola to the base of the breast.
There is one technical point patients should understand, because it accounts for a large share of revision surgery. In grades II and III, placing an implant without rearranging the gland is not enough: the original inframammary fold keeps its imprint and the deformity reappears in a new form, the double bubble. The reference review insists on glandular rearrangement using parenchymal flaps of the kind described by Puckett or Ribeiro, and warns that it would be delusive to think every type of tuberous breast can be corrected by the same one-step technique.
The main scar is periareolar, sitting on the border between the pigmented areola and the breast skin, which makes it discreet once mature. Forms that require a larger skin reduction may need a vertical scar, or an inverted-T scar whose horizontal limb is tucked into the inframammary fold. A scar takes around a year on average to soften and fade, and its final appearance depends as much on the patient’s own healing as on the technique used.
Following post-operative instructions has a direct bearing on the result. A compression dressing is worn for the first twenty-four hours to limit bleeding at the operated sites. Healing strips are removed between the twelfth and the fifteenth day. Painkillers are prescribed, particularly where lipofilling required liposuction, since the donor areas stay tender and may bruise for several weeks.
Ordinary daily life resumes after a few days of rest, with physical activity restricted for several weeks; UK surgeons commonly advise planning for a six-week recovery window, the first fortnight of which is largely rest. A support bra is worn day and night for at least a month. The result is judged roughly a year after surgery, once swelling has settled and the scars have matured. The corrected breast then remains subject to weight change, pregnancy and skin ageing, like the rest of the body.
The complication rate for this operation is not negligible, and it is better known than glossed over. A systematic review published in the Aesthetic Surgery Journal in 2023, covering 38 studies and 897 patients with a mean follow-up of 39 months, reports an overall complication rate of 20%. Reported satisfaction in those same series remains very high, with a mean BREAST-Q score of 86.7 out of 100. Those two findings describe the same reality rather than contradicting each other: complications are common, most are manageable, and patients consider the outcome worthwhile.
Early events are haematoma, irritation of the scars, infection and bleeding, and they should be reported to the surgeon as soon as they appear. Later problems include residual asymmetry, implant-related complications, hypertrophic scarring and altered sensation in the nipple and surrounding skin. Three complications are specific to tuberous breasts: recurrence of the tubular shape, secondary enlargement of the areola, and the double bubble described above.
How many operations you should expect depends on which route is taken for volume, and a Finnish study of 129 patients treated between 2010 and 2020 puts numbers on it.
| Finnish series, 129 patients | Observed result |
|---|---|
| Operations, implant route | 1.2 on average |
| Operations, lipofilling route | 2.4 on average |
| Revision at 5 years, implant | 46% of patients |
| Revision at 5 years, lipofilling | 21% of patients |
Lipofilling therefore takes more sessions to reach the intended volume, because grafted fat is partly resorbed between stages, but it leads to fewer revisions over five years. All six major complications in that series occurred in implant patients. A French comparative study published in 2026 on 40 patients fills in the picture: satisfaction with breasts, psychosocial well-being and sexual well-being scored similarly on both routes, while lipofilling scored better for physical well-being and for satisfaction with the outcome.
Numbness of the breast and nipple in the weeks following surgery is usual, and sensation most often returns gradually. That return is not guaranteed. The NHS lists nerve problems in the nipples among the risks of breast surgery, noting that the nipple may become more sensitive, less sensitive or completely numb, either temporarily or permanently. It is also one of the reasons French surgeons give for not operating too early. This is a point to raise explicitly at consultation, not to assume.
A widely repeated reassurance needs correcting here, because it can lead to poorly prepared decisions. Tuberous breasts are a form of breast hypoplasia, meaning a shortfall of glandular tissue, and hypoplasia is associated with difficulty producing enough milk. A systematic review in Breastfeeding Medicine pooled the seven available studies, covering 42 women in total: forty of them had stopped exclusive breastfeeding before one month postpartum. Cleveland Clinic puts it in plain terms, stating that tubular breasts can make breastfeeding difficult because milk supply may be lower than normal.
These studies rest on small numbers and on women who were already seeking help for low supply, which rules out any individual prediction. A survey of 399 women reporting insufficient milk production found that around 68% described at least one atypically shaped breast, a marker among several, not a diagnosis. Nothing therefore prevents a woman with tuberous breasts from breastfeeding, but it is worth arranging support from a lactation consultant in advance rather than relying on a guarantee that does not exist. Corrective surgery does not restore missing glandular tissue: it changes the shape of the breast, and no published data supports the claim that it improves lactation.
The NHS does not routinely fund breast surgery carried out for appearance. Its own guidance states that you cannot usually get breast enlargement on the NHS, with exceptions in specific situations such as markedly asymmetrical breasts or absent breast development, and those exceptions depend on where you live.
The route is a GP referral to a plastic surgeon, followed by a funding decision. One correction to older guidance matters here: clinical commissioning groups no longer exist. The Health and Care Act 2022 established integrated care boards, expressly including by re-purposing clinical commissioning groups, and it is your local integrated care board that now sets the criteria and decides whether a case meets them. Those criteria vary between boards, and the threshold is high: a case is usually argued on documented physical and psychological impact rather than on shape alone. Waiting times for the initial assessment alone can run into months, with a further wait for surgery if funding is agreed.
Where funding is refused or the wait is unacceptable, correction is available privately. A private quotation should be read in full rather than as a single headline figure, and it should itemise the surgeon’s and anaesthetist’s fees, the hospital stay, the implants where they are used, the follow-up appointments included, and what happens financially if a second stage proves necessary. That last line matters more here than in most breast operations, given the revision rates above.
Cost and waiting times lead some patients to look abroad. Body Expert arranges these trips to Türkiye with partner clinics selected against its own quality criteria, and quotes savings of up to 70% against French prices. The stay covers the hotel with breakfast, private transfers, a dedicated English-speaking patient coordinator and twelve months of post-operative follow-up; flights remain the patient’s own expense. The NHS advises against flying too soon after surgery and recommends not flying for five to seven days after breast surgery, a constraint any travel plan needs to account for. No surgery of this kind comes with a guaranteed result, in Türkiye or anywhere else.
Published series report high satisfaction after correction, and they also report a 20% complication rate and frequent revisions. That gap is what preparation should address: find a surgeon who operates on this specific deformity regularly, and accept from the outset that a staged plan is sometimes the right answer rather than a sign that something went wrong.
A successful tuberous breast correction shows three things: a widened breast base, a filled lower pole and a proportionate areola. Those three objectives are what a consultation should settle, grade by grade, before price enters the conversation.
Alvaro, A. I., Willet, J. W., Dounas, G. D., Jeeves, A., Lodge, M., & Javed, M. U. (2023). A systematic review of outcomes and complications of tuberous breast surgery. Aesthetic Surgery Journal, 43(12), NP1001-NP1009. https://doi.org/10.1093/asj/sjad229
Cleveland Clinic. (2026). Tubular breasts. https://my.clevelandclinic.org/health/diseases/tubular-breasts
Dibiase, L., Ruiz, F., Haye, B., Ramelli, E., Schohn, T., Kara, P., Wessels, A., & Bodin, F. (2026). Comparative study of patient-reported outcomes following autologous fat grafting versus implant-based augmentation in tuberous breast deformity. Aesthetic Plastic Surgery, 50(13), 5081-5090. https://doi.org/10.1007/s00266-026-05902-3
Duquennoy-Martinot, V., Calibre, C., Guerreschi, P., Belkhou, A., & Barry, L. (2022). Est-il légitime de proposer une chirurgie de la région mammaire avant la fin de la puberté ? [Is it legitimate to propose surgery of the breast area before the end of puberty?]. Annales de Chirurgie Plastique Esthétique, 67(5-6), 425-437. https://doi.org/10.1016/j.anplas.2022.06.007
Ellart, J., Chaput, B., & Grolleau, J. L. (2016). Seins tubéreux [Tuberous breast: Current concept]. Annales de Chirurgie Plastique Esthétique, 61(5), 640-651. https://doi.org/10.1016/j.anplas.2016.08.003
González-Prieto, J., González-Nicolás, A., & Barcaro Machado, B. H. (2026). Conical implants in tuberous breast correction: Clinical and patient-reported outcomes. Medicina, 62(5), 930. https://doi.org/10.3390/medicina62050930
Health and Care Act 2022, c. 31, s. 19 (UK). https://www.legislation.gov.uk/ukpga/2022/31/section/19/enacted
Kam, R. L., Amir, L. H., & Cullinane, M. (2021). Is there an association between breast hypoplasia and breastfeeding outcomes? A systematic review. Breastfeeding Medicine, 16(8), 594-602. https://doi.org/10.1089/bfm.2021.0032
Kam, R. L., Amir, L. H., Cullinane, M., Ingram, J., Li, X., & Nommsen-Rivers, L. A. (2024). Breast hypoplasia markers among women who report insufficient milk production: A retrospective online survey. PLOS ONE, 19(2), e0299642. https://doi.org/10.1371/journal.pone.0299642
National Health Service. (2026). Breast enlargement (implants). https://www.nhs.uk/conditions/cosmetic-procedures/breast-enlargement/
National Health Service. (2026). Cosmetic surgery abroad. https://www.nhs.uk/conditions/cosmetic-procedures/cosmetic-surgery-abroad/
Surcel, E. S., Merkkola-von Schantz, P. A., Öhman, H., & Kauhanen, S. C. (2024). Long-term results of the tuberous breast: What to expect after the primary correction process? Scandinavian Journal of Surgery, 113(3), 246-253. https://doi.org/10.1177/14574969241250213